Aimmune Therapeutics, Inc. Uncategorized Contracts & Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Commercial Packaging Agreement, dated November 11, 2019, by and between AndersonBrecon Inc. and Aimmune Therapeutics, Inc
Aimmune Therapeutics, Inc.
Biotechnology
NY
2020
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Aimmune Therapeutics, Inc.
Biotechnology
2020
Amended and Restated Standstill Agreement, dated February 4, 2020, by and between the Company and Nestle Health Science US Holdings, Inc
Aimmune Therapeutics, Inc.
Biotechnology
NY
2020
Letter Agreement, dated December 19, 2019, between the Company and Stephen G. Dilly, M.B.B.S., Ph.D
Aimmune Therapeutics, Inc.
Biotechnology
2019
Letter Agreement, dated June 13, 2019, by and between the Company and Stephen G. Dilly, M.B.B.S., Ph.D
Aimmune Therapeutics, Inc.
Biotechnology
2019
Amended and Restated Standstill Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc
Aimmune Therapeutics, Inc.
Biotechnology
NY
2019
Nestle Health Science US Holdings, Inc. 900 Long Ridge Road, Building 2 Stamford, CT 06902
Aimmune Therapeutics, Inc.
Biotechnology
NY
2017
Jeff Knapp
Aimmune Therapeutics, Inc.
Biotechnology
2016